Effect of Micronutrients and Exercise During Pregnancy on Factors Related With Non-Transmissible Chronic Diseases
1 other identifier
interventional
320
1 country
1
Brief Summary
At the moment, most of efforts to prevent non-transmissible chronic diseases at population level have been centered in promoting healthful behaviors like physical activity, consumption of fruits and vegetables, and discouraging from the consumption of tobacco and alcohol in adult population, but the results have been little hopeful. In the last years, manifold studies have indicated the relation between metabolic alterations and of the fetal growth with the development of non-transmissible chronic diseases in adult age. More recently, it has been proposed that maternal factors (endothelial function, oxidative stress and alterations in adipokines) and placental ones (mitochondrial dysfunction) are the precursory mechanisms of fetal metabolic alterations and of the later development of non-transmissible chronic diseases. Also, it has been suggested that possibly supplementation with micronutrients and the physical exercise during the gestation can regulate these maternal and placental factors. For the reasons just mentioned, it is necessary to clarify if these proposed factors are related to fetal metabolic alterations and if the supplementation during the gestation with micronutrients and/or the physical exercise can regulate them, which would be an early and novel alternative to fortify the prevention of non-transmissible chronic diseases in the population. Purpose
- 1.To evaluate the effect of associated both the maternal and placental metabolic factors to non-transmissible chronic diseases in newborn.
- 2.To evaluate the effect of the physical exercise and the complementation with micronutrients during the pregnancy either in the endothelial function, the levels of adipokines, the oxidative stress of the mother and the newborn, as in the placental mitochondrial function and the anthropometry of newborn.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2009
CompletedFirst Posted
Study publicly available on registry
March 31, 2009
CompletedStudy Start
First participant enrolled
March 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2012
CompletedOctober 15, 2018
October 1, 2018
8 months
March 27, 2009
October 10, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Endothelium-dependent flow mediated dilation
Baseline / week 32-36 of gestation
Secondary Outcomes (5)
Biomarkers of endothelial function in blood from umbilical vein and maternal blood
Baseline / 32-36 weeks gestation and delivery
Markers of mitochondrial function
Baseline / 32-36 weeks gestation and delivery
Neonatal and maternal anthropometric indicators
Baseline / 32-36 weeks gestation and delivery
Quality of life SF-12
Baseline / 32-36 weeks gestation and delivery
Functional capacity (VO2max)
Baseline / 32-36 weeks gestation and delivery
Study Arms (4)
1
OTHERRegular aerobic physical exercise + placebo
2
OTHERActivities of daily living + Micronutrients
3
OTHERRegular aerobic exercise + micronutrients
4
PLACEBO COMPARATORActivities of daily living + placebo
Interventions
Walking (10 minutes), aerobic exercise (30 minutes), stretching (10 minutes) and relaxation exercise (10 minutes). Exercise will be performed at three sessions per week. All sessions will be supervised by a physical therapist and a physical educator.
Zinc 30mg, Magnesium 400mg, Beta-carotene 9 mg, Tocopherol 30mg, vitamin C 200mg y Niacin 100mg.
Basic activities of daily living (bathing, dressing, eating, walking) without counseling by a physical therapist and prenatal care. Placebo Comparator: Equivalent to placebo (maltodextrin).
Eligibility Criteria
You may qualify if:
- Primiparous women who have not participated in a structured exercise program, including significant amounts of walking for the past four months are eligible for the trial.
- Live fetus at the routine ultrasound scan and a normal pregnancy.
- Gestational age 16 to 20 weeks
You may not qualify if:
- History of high blood pressure
- Chronic medical illnesses (cancer, renal, endocrinologic, psychiatric, neurologic, infectious and cardiovascular diseases)
- Persistent bleeding after week 12 of gestation
- Poorly controlled thyroid disease
- Placenta praevia, incompetent cervix, polyhydramnios, oligohydramnios
- History of miscarriage in the last twelve months
- Diseases that could interfere with participation (following recommendations from ACSM 2000, ACOG 2003).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidad del Valle, Colombialead
- Fundación FEScollaborator
- Fundación Cardiovascular de Colombiacollaborator
- Instituto Nacional de Saludcollaborator
- University College, Londoncollaborator
Study Sites (1)
Ana C Plata, MSc
Cali, Valle del Cauca Department, Colombia
Related Publications (2)
Robledo-Colonia AF, Sandoval-Restrepo N, Mosquera-Valderrama YF, Escobar-Hurtado C, Ramirez-Velez R. Aerobic exercise training during pregnancy reduces depressive symptoms in nulliparous women: a randomised trial. J Physiother. 2012;58(1):9-15. doi: 10.1016/S1836-9553(12)70067-X.
PMID: 22341377DERIVEDRamirez-Velez R, Romero M, Echeverri I, Ortega JG, Mosquera M, Salazar B, Giron SL, Saldarriaga W, Aguilar de Plata AC, Mateus JC. A factorial randomized controlled trial to evaluate the effect of micronutrients supplementation and regular aerobic exercise on maternal endothelium-dependent vasodilatation and oxidative stress of the newborn. Trials. 2011 Feb 28;12:60. doi: 10.1186/1745-6215-12-60.
PMID: 21356082DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ana C Plata, MSc
Universidad del Valle, Colombia
- STUDY CHAIR
Julio Cesar Mateus, MD, MEpi
Fundación FES, División de Salud. Colombia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
March 27, 2009
First Posted
March 31, 2009
Study Start
March 1, 2011
Primary Completion
November 1, 2011
Study Completion
March 1, 2012
Last Updated
October 15, 2018
Record last verified: 2018-10